LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

Search

West Pharmaceutical Services Inc

Chiusa

SettoreSettore sanitario

271.09 5.31

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

269.36

Massimo

271.15

Metriche Chiave

By Trading Economics

Entrata

8.2M

140M

Vendite

38M

804M

P/E

Media del settore

38.933

106.172

EPS

1.96

Rendimento da dividendi

0.32

Margine di Profitto

17.406

Dipendenti

10,600

EBITDA

19M

217M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+28.96% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.32%

2.31%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-889M

19B

Apertura precedente

265.78

Chiusura precedente

271.09

Notizie sul Sentiment di mercato

By Acuity

50%

50%

151 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 nov 2025, 22:23 UTC

Acquisizioni, Fusioni, Takeovers

BHP Abandons Bid for Anglo American Following New Talks

23 nov 2025, 22:16 UTC

Acquisizioni, Fusioni, Takeovers

Macquarie Proposes $7.5 Billion Takeover of Logistics Operator Qube

23 nov 2025, 22:01 UTC

Acquisizioni, Fusioni, Takeovers

Macquarie Proposes $7.5B Takeover of Logistics Operator Qube

23 nov 2025, 19:00 UTC

Utili

Dell, HP Inc., Alibaba, Zoom, Deere, and More Stocks to Watch This Week -- Barrons.com

23 nov 2025, 00:50 UTC

Utili

Wall Street Goes on a Wild Ride: 'No One Was Expecting This' -- WSJ

22 nov 2025, 10:30 UTC

Utili

How Google Finally Leapfrogged Rivals With New Gemini Rollout -- WSJ

22 nov 2025, 10:30 UTC

Acquisizioni, Fusioni, Takeovers

Investors Clamor for a Peek Behind the Private Markets Curtain -- WSJ

22 nov 2025, 09:20 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

21 nov 2025, 22:42 UTC

Discorsi di Mercato

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21 nov 2025, 21:50 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

21 nov 2025, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

21 nov 2025, 21:47 UTC

Discorsi di Mercato

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21 nov 2025, 21:43 UTC

Discorsi di Mercato

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21 nov 2025, 20:18 UTC

Discorsi di Mercato

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21 nov 2025, 20:14 UTC

Discorsi di Mercato

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21 nov 2025, 19:48 UTC

Discorsi di Mercato

Precious Metals Fall for the Week -- Market Talk

21 nov 2025, 19:44 UTC

Utili

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21 nov 2025, 19:37 UTC

Discorsi di Mercato

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21 nov 2025, 19:27 UTC

Discorsi di Mercato
Utili

Global Equities Roundup: Market Talk

21 nov 2025, 19:27 UTC

Discorsi di Mercato
Utili

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21 nov 2025, 19:20 UTC

Discorsi di Mercato

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21 nov 2025, 18:44 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21 nov 2025, 18:37 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21 nov 2025, 18:34 UTC

Discorsi di Mercato
Utili

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21 nov 2025, 18:28 UTC

Utili

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21 nov 2025, 18:03 UTC

Discorsi di Mercato

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21 nov 2025, 17:24 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

21 nov 2025, 17:24 UTC

Discorsi di Mercato

Intuit Seen on Path to Increase Growth -- Market Talk

21 nov 2025, 17:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

21 nov 2025, 17:05 UTC

Discorsi di Mercato

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

28.96% in crescita

Previsioni per 12 mesi

Media 349.56 USD  28.96%

Alto 375 USD

Basso 311 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

11 ratings

10

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

213.26 / 219.27Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

151 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat